Omron Healthcare and China Jo-Jo Drugstores Launch Atrial Fibrillation Screening Zone

Omron Healthcare and China Jo-Jo Drugstores Launch Atrial Fibrillation Screening Zone

A joint effort between Japan-based Omron Healthcare and China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD), a large open-shelf affordable pharmacy headquartered in Hangzhou, the atrial fibrillation (AF) risk screening zone became operational late last week. The initiative aims to help the public better identify the risk of atrial fibrillation and raise health awareness.

Screening Zone Features
The atrial fibrillation risk screening area provides consumers with an immersive health screening experience through customized scene design. Consumers can utilize Omron’s devices for AF risk screening in the designated area and enhance their disease awareness and prevention consciousness by acquiring AF knowledge.

Future Plans
Moving forward, the two companies plan to promote the atrial fibrillation risk screening zone in more drugstores in Hangzhou, expanding the initiative’s reach and impact on public health.-Fineline Info & Tech

Leave a Reply

Your email address will not be published. Required fields are marked *

Insight, China's Pharmaceutical Industry